Table 2 TRPM7methylation in breast cancer: univariate and multivariate models with clinicopathological characteristics

Age^b

1.04 (0.84–1.28)

/

/

WHO grade^c

0.66 (0.37–1.18)

/

/

Molecular subtype^d

1.27 (1.00–1.63)

1.34 (0.94–1.90)

0.10

LNM^e

0.09 (0.04–0.22)

0.09 (0.03–0.27)

0.001

ER

1.43 (0.81–2.50)

PR

1.33 (0.77–2.29)

Her2

0.61 (0.31–1.20)

Endocrine therapy

1.43 (0.81–2.50)

1.45 (0.76–2.76)

0.26

Radiotherapy

0.37 (0.21–0.64)

0.94 (0.36–2.44)

0.90

Chemotherapy

0.56 (0.26–1.20)

0.09 (0.31–1.97)

0.61

Relapse

0.63 (0.29–1.38)

3.25 (0.49–21.58)

0.22

Survival status^f

0.49 (0.23–1.05)

0.20 (0.03–1.21)

0.07